Bidulka, P. ., Mathur, R. ., Lugo-Palacios, D. G., O’Neill, S. ., Basu, A. ., Silverwood, R. J., … Grieve, R. . (2022). Ethnic and socioeconomic disparities in initiation of second-line antidiabetic treatment in people with type 2 diabetes in England: a cross-sectional study. Diabetes Obes Metab. http://doi.org/10.1111/dom.14874
pharmacoepidemiology
Eroglu, T. E., Coronel, R. ., Zuurbier, C. J., Blom, M. ., de Boer, A. ., & Souverein, P. C. (2022). Use of sodium-glucose cotransporter-2 inhibitors and the risk for sudden cardiac arrest and for all-cause death in patients with type 2 diabetes mellitus. Eur Heart J Cardiovasc Pharmacother. http://doi.org/10.1093/ehjcvp/pvac043
Persson, R. ., Hagberg, K. W., Vasilakis-Scaramozza, C. ., Yelland, E. ., Williams, T. ., Myles, P. ., & Jick, S. S. (2022). Presence of Codes for Indication for Use in Clinical Practice Research Datalink Aurum: An Assessment of Benign Prostatic Hyperplasia Treatments. Clin Epidemiol, 14, 641–652. http://doi.org/10.2147/clep.s360843
van Sloten, T. T., Souverein, P. C., Stehouwer, C. D., & Driessen, J. H. (2022). Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers and risk of depression among older people with hypertension. J Psychopharmacol, 2698811221082470. http://doi.org/10.1177/02698811221082470
Penner, L. S., Gavan, S. P., Ashcroft, D. M., Peek, N. ., & Elliott, R. A. (2022). Does co-prescribing non-steroidal anti-inflammatory drugs and oral anticoagulants increase the risk of major bleeding, stroke and systemic embolism?. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.15371
Pradhan, R. ., Patorno, E. ., Tesfaye, H. ., Schneeweiss, S. ., Yin, H. ., Franklin, J. ., … Azoulay, L. . (2022). Glucagon-Like Peptide-1 Receptor Agonists and Risk of Anaphylactic Reaction Among Patients With Type 2 Diabetes: Multisite Population-Based Cohort Study. Am J Epidemiol. http://doi.org/10.1093/aje/kwac021